Community/Retail

This month's generic product news features clarithromycin, sevelamer hydrochloride, and metronidazole.

Pharmacists are an important touch point for PQA, and they're starting small and thinking big.

Any antibiotic use was associated with higher rates of IBD, and the risk went up substantially with each course.

Linaclotide (Linzess) is indicated in adults for treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation.

CalmAid helps reduce stress and tension.

With the new approval, manufacturers believe 7000 new rings will be able to enter the supply chain and will be available to customers in the second and third quarters of 2022.

PQA is focused on actually testing the feasibility and implementation of some of these measures as concepts.

Dong Xu, PhD, MS, curators' distinguished professor at the University of Missouri College of Engineering, discusses how the use of artificial intelligence may help develop new drug therapies targeting multiple disease states.

Pet peeves are brought to you by The Sassy Pharmacist.

This month's Rx product news features empagliflozin, mitapivat, and RSVpreF.

Sacubitril/valsartan (Entresto)reduces the risk of hospitalization and death related to cardiovascular complications in patients with heart failure.

Investigators found that 51% of participants achieved sustained unresponsiveness to peanut after 18 months of treatment.

Sara Wettergreen, assistant professor in the department of Clinical Pharmacy, and Department of Family Medicine, at Skaggs School of Pharmacy and Pharmaceutical Sciences, on burnout and mental health concerns among pharmacy technicians

Without sufficient vitamin D exposure, bones can become thin, brittle, or misshapen; however, excessive amounts of vitamin D are toxic.

Dong Xu, PhD, MS, curators' distinguished professor at the University of Missouri College of Engineering, discusses how artificial intelligence is being used to develop new drug therapies for medical treatments targeting cancers and other diseases.

One example that has already been done in the past relates to understanding how to better measure insulin persistence.

This month's OTC Cases focuses on heartburn, pinworm infection, and food poisoning.

The FDA has approved abrocitinib tablets to treat adults with moderate-to-severe, refractory atopic dermatitis.

In patients already using analgesics for pain control, pharmacists need to address medication adherence for improved osteoarthritis symptom control.

Issues like medication access and transportation cost all impact a patient's ability to have access to medications and use them safely and effectively.

The vaccine is also credited with saving more than $30 billion in health care costs and more than $40 billion in lost productivity.

Murray Aitken, executive director of IQVIA Institute for Human Data Science, discusses whether patient out of pocket costs rose in 2021, and what the implications may be for the health care system and for patients in 2022.

Comfort Ear soothes dry, irritated ears.

It's really opening up the world for pharmacists to develop more meaningful measures and get at patient reported and clinical outcome measures.

Here are 9 tips for employers to address employees’ feeling of detachment, exhaustion, and reduced accomplishment.

This month's product news features beet gummies, nerve relief, and acne blemish patches.

Approved by the FDA in 2021, finerenone is the only non-steroidal mineralocorticoid receptor antagonist that reduces the risk of renal disease progression and cardiovascular events in adults with type 2 diabetes mellitus-mediated chronic kidney disease.

Murray Aitken, executive director of IQVIA Institute for Human Data Science, discusses the implications of the increase in spending on medicines in the United States in 2021.